Ownership history in Frazier Life Sciences Management, L.P. · 16 quarters on record
This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in TARSUS PHARMACEUTICALS INC (TARS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 728,644 | -438,883 | -37.6% | 1.60% | $59.7M | $81.88 |
| 2025 Q3 | REDUCED | 1,167,527 | -230,000 | -16.5% | 2.08% | $69.4M | $59.43 |
| 2025 Q2 | UNCHANGED | 1,397,527 | — | 0% | 2.26% | $56.6M | $40.51 |
| 2025 Q1 | REDUCED | 1,397,527 | -190,000 | -12.0% | 3.28% | $71.8M | $51.37 |
As of 2025 Q4 — sorted by position size